These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Experience of immunotherapy with leukinferon in the comprehensive therapy of breast cancer]. Korobkova LI; Kuznetsov VP; Rasskazchikova ES; Beliaev DL; Vel'sher LZ; Babadiants AA; Zverev MP; Strekalovskiĭ SV; Zueva LA Vopr Onkol; 1994; 40(7-12):309-13. PubMed ID: 7610626 [TBL] [Abstract][Full Text] [Related]
15. [The use of a complex preparation of alpha-interferon and first-phase immune-response cytokines--leukinferon]. Gruzdeva TA; Kuznetsov VP; Beliaev DL; Vakhman IS; Fedorova NV; Babaiants AA; Polikarpova EV Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):59-64. PubMed ID: 8184616 [TBL] [Abstract][Full Text] [Related]
16. [The use of leukinferon in treating zoonotic cutaneous leishmaniasis. 1. Research on an experimental model in mice]. Shuĭkina EE; Sergiev VP; Kuznetsov VP; Beliaev DL; Fediainova IE Med Parazitol (Mosk); 1993; (2):28-31. PubMed ID: 8028564 [TBL] [Abstract][Full Text] [Related]
17. [The combined therapy of patients with gonorrheal-chlamydial urogenital infections by leukinferon immunocorrection]. Kuznetsov VP; Dubenskiĭ VV; Delektorskiĭ VV; Igoshin IuM; Beliaev DL; Iashkova GN; Babaiants AA Ter Arkh; 1993; 65(11):39-42. PubMed ID: 8108795 [TBL] [Abstract][Full Text] [Related]
18. [Approaches to the combined therapy of helminthiases with leukinferon and etiotropic preparations]. Lebedeva MN; Malysheva NS; Fedianina LV; Shuĭkina EE; Gitsu GA Med Parazitol (Mosk); 1998; (1):15-7. PubMed ID: 9608202 [TBL] [Abstract][Full Text] [Related]